Estrogen receptor-positive (ER+) human epidermal growth factor receptor 2-negative (HER2−) breast cancer is the most common subtype, accounting for more than 60% of the metastatic breast cancers (MBCs) [4]. This evidence concerns the gene ERBB2 and breast cancer.